Medicare Enrolled

Dr. Garo Pehlevanian, M.D.

Cardiovascular Disease · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
5250 SANTA MONICA BLVD, Los Angeles, CA 90029
3236640857
In practice since 2006 (20 years)
NPI: 1417919507 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pehlevanian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pehlevanian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pehlevanian

Dr. Garo Pehlevanian is a cardiovascular disease specialist in Los Angeles, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pehlevanian performed 2,928 Medicare services across 1,579 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pehlevanian received a total of $7,338 from 32 pharmaceutical and/or device companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pehlevanian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 37% volume in CA $7,338 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,928
Medicare services
Top 37% in CA for cardiovascular disease
1,579
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~146 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
977 $41 $120
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
610 $98 $250
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
576 $12 $80
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
325 $166 $750
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
238 $137 $250
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
114 $8 $45
New patient office visit, complex (60-74 min) 64 $160 $525
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
24 $78 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.1% high complexity
0.0% medium
88.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,338
Total received (2018-2024)
Avg $1,048/year across 7 years
Top 33% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
362
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,338 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$551
2023
$535
2022
$899
2021
$1,642
2020
$946
2019
$1,191
2018
$1,575

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$176
Otsuka America Pharmaceutical, Inc.
$108
Lilly USA, LLC
$96
Amgen Inc.
$55
Novartis Pharmaceuticals Corporation
$44
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$25
Sumitomo Pharma America, Inc.
$25
Novo Nordisk Inc
$22
Top 3 companies account for 69.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$893
Amgen Inc.
$757
PFIZER INC.
$634
Janssen Pharmaceuticals, Inc
$582
Lilly USA, LLC
$531
Takeda Pharmaceuticals U.S.A., Inc.
$461
Amarin Pharma Inc.
$442
Novartis Pharmaceuticals Corporation
$384
Novo Nordisk Inc
$315
Kowa Pharmaceuticals America, Inc.
$291
Allergan Inc.
$290
Ironwood Pharmaceuticals, Inc
$227
E.R. Squibb & Sons, L.L.C.
$206
IRONWOOD PHARMACEUTICALS, INC
$178
ARBOR PHARMACEUTICALS, INC.
$143
Gilead Sciences, Inc.
$140
AbbVie Inc.
$121
Otsuka America Pharmaceutical, Inc.
$108
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$106
Arbor Pharmaceuticals, Inc.
$90
Allergan, Inc.
$89
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
Bayer HealthCare Pharmaceuticals Inc.
$78
Biohaven Pharmaceuticals, Inc.
$25
Sumitomo Pharma America, Inc.
$25
Corium, LLC
$25
Astellas Pharma US Inc
$22
Esperion Therapeutics, Inc.
$21
GlaxoSmithKline, LLC.
$21
Merck Sharp & Dohme Corporation
$17
West-Ward Pharmaceuticals
$15
Regeneron Healthcare Solutions, Inc.
$15
Top 3 companies account for 31.1% of all-time payments
Associated products mentioned in payments ›
ADLARITY · Aimovig · BRILINTA · BYSTOLIC · CHANTIX · Corlanor · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · GEMTESA · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LIVALO · LOKELMA · LYRICA · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · NEXLETOL · NURTEC ODT · Otezla · Ozempic · PRALUENT · Prolia · REXULTI · Repatha · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Trintellix · UBRELVY · VRAYLAR · Vascepa · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease specialist in Los Angeles?
Compare cardiologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
602
Per 100K population
6.1
County median income
$87,760
Nearest hospital
L A DOWNTOWN MEDICAL CENTER
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pehlevanian is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pehlevanian experienced with home health plan of care certification?
Based on Medicare claims data, Dr. Pehlevanian performed 977 home health plan of care certification services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pehlevanian receive payments from pharmaceutical companies?
Yes. Dr. Pehlevanian received a total of $7,338 from 32 companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pehlevanian's costs compare to other cardiologists in Los Angeles?
Dr. Pehlevanian's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pehlevanian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →